Cite

HARVARD Citation

    Henry, T. et al. (2016). Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study. Cell transplantation. 25 (9), pp. 1701-1711. [Online]. 
  
Back to record